FDA Inspection 1108245 — Celltrion Inc.

Celltrion Inc. — FEI 3005241015

The FDA completed an inspection of Celltrion Inc. on October 22, 2019 in Yeonsu. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 22, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yeonsu (Korea (the Republic of))

Citations

IDCFRDescription
143321 CFR 211.42(c)(10)(iii)Air Supply